Showing results (191-200 of 237) with videos related to
Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group studyS E Rivkin, S Green, J O'Sullivan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group studyS E Rivkin, S Green, B Metch, et al.Breast Cancer Research and Treatment|January 8, 1999
Expanded phase II trial of paclitaxel in metastatic breast cancer: a Southwest Oncology Group studyC E Geyer, S J Green, C M Moinpour, et al.Oncogenesis|August 21, 2013
NeuroD1 regulation of migration accompanies the differential sensitivity of neuroendocrine carcinomas to TrkB inhibitionJ K Osborne, J E Larsen, J X Gonzales, et al.Journal of the National Cancer Institute|May 17, 1995
Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancerC K Osborne, E B Coronado-Heinsohn, S G Hilsenbeck, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group StudyS E Rivkin, S Green, B Metch, et al.Human Pathology|September 1, 1992
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancerD C Allred, G M Clark, R Molina, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group StudyR M Elledge, S Green, D Ciocca, et al.Journal of the National Cancer Institute|August 17, 1991
Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group studyJ D Cowan, J Neidhart, S McClure, et al.Biochemistry and Biophysics Reports|September 29, 2025
LIN28-mediated gene regulatory loops synchronize transitions throughout organogenesisIndhujah Thevarajan, Maria F Osuna, Sonia Fuentes Lewey, et al.Pageof 24